You are here

The Frontal Pole: An Emerging TMS Treatment Target for Drug and Alcohol use Disorders

The Frontal Pole: An Emerging TMS Treatment Target for Drug and Alcohol Use Disorders

You’re invited to join the Clinical TMS Society for this installment of our Grand Round Webinar Series: The Frontal Pole: An Emerging TMS Treatment Target for Drug and Alcohol Use Disorders

Learning objectives: 

1.     Learn techniques which promote comfort, compliance, and feasibility of frontal polar TMS;

2.     Learn the scientific basis for choosing the frontal pole as a target;  

3.     Learn about recent studies in cocaine and alcohol users that have used this target. 

 

Date: Tuesday, June 2, 2020

Time: 5:00 pm PDT / 8:00 pm EDT

Format: LIVE

Cost: Members: $25 | Non-members $50 | Student Members FREE


Speaker: Colleen Hanlon, PhD

Dr. Hanlon is a professor in the Department of Cancer Biology at Wake Forest University Health Sciences. She received her undergraduate degree at the University of Florida, Ph.D. in Neurobiology from Duke University, did a postdoctoral fellowship in Addiction with Linda J. Porrino, Ph.D., and was trained to do TMS from Mark S. George, M.D. at the Medical University of South Carolina – wherein she spent the majority of her career  to date.   Now at Wake Forest University, she leads the Clinical Neuromodulation Program which is devoted to understanding the basic neurobiological effects of brain stimulation techniques (e.g. TMS, TDCS, Ultrasound) as well as developing evidence-based therapeutic strategies for smoking, alcohol use disorders, and pain.   She collaborates with teams of preclinical researchers in the Department of Physiology and Pharmacology and clinician scientists in the Departments of Neurology, Psychiatry, and Anesthesiology/pain management.   She was given an Early Career Investigator award from the National Institute of Drug Abuse in 2011 and is the senior author on the first “Consensus Paper” published by a group of over 70 scientists from over 10 countries outlining the path forward for Non-Invasive Therapeutic Development for Addiction.

In addition to serving as a principal investigator on several NIH-funded awards devoted to brain imaging and brain stimulation, she is also an eager teacher - participating in the research training and education community at both a local level (serving as a mentor to over 50 medical, graduate, post-graduate, and fellowship trainees since 2005 on a national and international scale) and national level.  She directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation, and lead their social medial research dissemination efforts through curation of their website and social media pages.  She has also lead an annual addiction outreach event at the College of Problems on Drug Dependence (CPDD) meeting (2015-2019), served on the Liaison Committee (2016-2019) and the Education and Training Committee (2019-present)  for the American College of Neuropsychopharmacology, Grassroots Advocacy Team for the Society for Neuroscience (2017-2019), Chair of the Education Outreach and Public Policy Committee for CPDD (2017-2019), ad hoc participation in over 20 NIH study sections, and serving as a standing member of NIH NPAS study section (effective 10/2018).  


Acknowledgement of Financial and/or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion 

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.   

Physicians             

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 

Questions? Email Certificate@AmedcoEmail.com

 

 

 

June 2nd, 2020 5:00 PM   through   6:00 PM
Phone: 845-392-3238
Email:
Fee Level
Webinar Registration | Member $ 25.00
Webinar Registration | Non-Member $ 50.00
Webinar Registration | Student $ 0.00
Webinar Registration | Associate Member $ 25.00
Grand Rounds Webinar
Grand Rounds Webinar Title The Frontal Pole: An Emerging TMS Treatment Target for Drug and Alcohol use Disorders
Timezone
Time Zone Pacific
Event Thumbnail
Thumbnail

Help spread the word

Please help us and let your friends, colleagues and followers know about our page: The Frontal Pole: An Emerging TMS Treatment Target for Drug and Alcohol use Disorders


You can also share the below link in an email or on your website.
https://www.clinicaltmssociety.org/civicrm/event/info?id=68&reset=1